It has been speculated that PRG, its cellular metabolites, and its derivatives (progestins) promote cellular proliferation through induced activation of MAPK signaling pathways in both nPR(+/-) breast cancer cells, which is independent of PRs and ERs (53). Here, WNK3 is linked to breast cancer.